Rachel E. Woolley

Rachel E. Woolley

Auto-generated profile, based on publicly available information

Rachel E. Woolley

Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Immunity
Verified
Journal Article
Closed access
NGNicholas A. Gherardin
Nicholas A. Gherardin
AKAndrew N. Keller
Andrew N. Keller
RWRachel E. Woolley
Rachel E. Woolley
JNJerome Le Nours
Jerome Le Nours
DRDavid S. Ritchie
David S. Ritchie
JRJamie Rossjohn
Jamie Rossjohn

3 June 2022 in Science Advances
Verified
Journal Article
Open access
MKMaia Kinnebrew
Maia Kinnebrew
RWRachel E. Woolley
Rachel E. Woolley
TAT. Bertie Ansell
T. Bertie Ansell
EBEamon F. X. Byrne
Eamon F. X. Byrne
SFSara Frigui
Sara Frigui
RRRajat Rohatgi
Rajat Rohatgi
Smoothened (SMO) transduces the Hedgehog (Hh) signal across the plasma membrane in response to accessible cholesterol. Cholesterol binds SMO at two sites: one in the extracellular cysteine-rich domain (CRD) and a second in the transmembrane domain (TMD). How these two sterol-binding sites mediate SMO activation in response to the ligand Sonic Hedgehog (SHH) remains unknown. We find that mutations in the CRD (but not the TMD) reduce the fold increase in SMO activity triggered by SHH. SHH also promotes the photocrosslinking of a sterol analog to the CRD in intact cells. In contrast, sterol binding to the TMD site boosts SMO activity regardless of SHH exposure. Mutational and computational analyses show that these sites are in allosteric communication despite being 45 angstroms apart. Hence, sterols function as both SHH-regulated orthosteric ligands at the CRD and allosteric ligands at the TMD to regulate SMO activity and Hh signaling.